NPR's Steve Inskeep speaks with Georgetown University law professor Stephen Vladeck about a recent pattern within the Supreme Court majority: issuing rulings with no written opinion.

It’s not every day that a political leader talking about the state of U.S. democracy is able to hit two tricky notes at the ...

Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...

While the Supreme Court’s conservative supermajority is pushing the law rightward, the justices appointed by GOP presidents ...

The courts continue to be the only bulwark against an overreaching executive, writes Nancy Gertner, a former U.S. District ...

The Supreme Court issued an order list on June 30 that contained both its follow-up to the disappointing ruling on June 18 in ...

Martin and Cliatt filed a lawsuit against the United States in federal court in Georgia. They relied on the Federal Tort Claims Act, which waives the federal government’s general immunity from ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million repayment order.

WASHINGTON, D.C. — State Attorney General Letitia James on Monday praised the Supreme Court’s decision not to hear an appeal from convicted “pharma bro” Martin Shkreli, leaving in place a ...

WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an order to ...

WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an ...

Emily Saul The U.S. Supreme Court on Monday declined to hear the appeal of former pharmaceutical executive Martin Shkreli that sought to wriggle him out of a $64.6 million judgment for inflating ...